SUMMARY Chlamydia trachomatis was reisolated from 11 of 12 men with gonorrhoea who had initiallv yielded chlamydiae and who had been treated with ampicillin and probenecid (AMP) only, but from none of five such men treated with ampicillin and probenecid followed by tetracycline (AMPT). These results correlated with the absence of postgonococcal urethritis (PGU) in the group treated with AMPT. C trachomatis was isolated or reisolated from 20 of 25 women after treatment with AMP, compared with none of 14 women treated with AMPT. We recommend the addition of a course of tetracycline to the routine single dose treatment for gonorrhoea in men and women.
Introduction
The combination of ampicillin and probenecid in single dosage is widely used for the treatment of uncomplicated gonorrhoea. Oral ampicillin in a dose of 2 g, plus oral probenecid (1 g) has been successfully used in both men and women attending the department of genitourinary medicine of this hospital for many years. In 1976 we reported that this regimen failed to eradicate concurrent infections with Chlamydia trachomatis in either sex. ' Since that time we have modified the regimen to include 500 mg oxytetracycline orally every six hours for seven days, starting 24 hours after the single dose of ampicillin and probenecid. We report here an analysis of the patients treated in 1976 with ampicillin and probenecid (AMP) and patients treated in 1981 with ampicillin and probenecid followed by a course of oxytetracycline (AMPT). Table II shows that 44 women with cervical gonorrhoea were treated with AMP, and C trachomatis was isolated from 23 (52%) before treatment; 40 were treated with AMPT, and C trachomatis was isolated from the cervix of 14 (35%). The difference in isolation rates between the two groups was not significant (X2 = 1 * 88; p>O-1). C trachomatis was reisolated from 18 (78%) of the 23 women initially positive in the group treated with AMP, compared with none of the 14 patients in the group treated with AMPT. This difference was highly significant (x2 = 17 e 54; p<0 001). In addition, two patients in the group treated with AMP who did not initially yield chlamydiae, yielded isolates after treatment, but no patient yielded isolates after treatment with AMPT.
Advantages of the addition of a course of tetracycline in the treatment of gonorrhoea Discussion In men AMPT eradicated C trachomatis from the urethra, and failure to reisolate C trachomatis after treatment with AMPT correlated with the absence of PGU in these patients. In the female patients AMPT was also successful in eradicating C trachomatis from the cervix.
Until chlamydial diagnostic services become more widely available, we think it is essential to recognise the possibility of concurrent infection with chlamydiae in patients with gonococcal infection. We do not advocate the use of tetracyclines alone to treat gonorrhoea and chlamydial infection. Gonococcal resistance to tetracycline is not uncommon,4 and this would preclude the use of a tetracycline in the absence of sensitivity testing. On the other hand, C trachomatis shows no resistance to tetracycline. The use of a course of tetracycline after standard single dose antigonococcal treatment has the important advantage of allowing flexibility of choice of the agent to be used against the gonococal infection (determined by local patterns of resistance including the prevalence of (3-lactamase producing strains) while curing the concurrent chlamydial infection. 
